Oryzon to Present its LSD1 programs in Acute Leukemias and in Neurodegenerative disorders at the GTC’s 3rd Epigenetics in Drug Discovery conference in Boston
02/05/2013
Notícies: 1-1 / 1
Arxiu
2013
